CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Operating activities
Net loss	$ (33,894)	$ (13,645)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	3,309	2,174
Non-cash interest expense	226	212
Stock-based compensation expense	3,266	1,470
Deferred taxes	99	(16)
Change in fair value of contingent consideration	(956)	826
Net accretion of marketable securities	(43)
Change in fair value of warrant liability		2,728
Loss (gain) on extinguishment of debt		(2,476)
Changes in operating assets and liabilities:
Accounts receivable, net	(1,028)	(1,688)
Prepaid expenses and other assets	(12,749)	(6,043)
Inventories, net	(4,131)	(2,539)
Accounts payable	3,937	(176)
Accrued expenses and other liabilities	9,591	1,923
Deferred revenue	1,055	431
Net cash used in operating activities	(31,318)	(16,819)
Investing activities
Purchases of property and equipment	(2,702)	(1,854)
Purchase of marketable securities	(40,774)
Net cash used in investing activities	(43,476)	(1,854)
Financing activities
Proceeds from initial public offering, net of underwriting discounts and commissions		138,553
Proceeds from stock option exercises	219	143
Proceeds from debt	10,000
Payments of debt issuance costs	(100)
Principal payments on capital leases		(176)
Principal payments on financing leases	(316)
Payments of contingent consideration	(1,207)	(1,590)
Net cash provided by financing activities	8,596	136,930
Net (decrease) increase in cash, cash equivalents, and restricted cash	(66,198)	118,257
Cash, cash equivalents, and restricted cash at beginning of year	113,381	17,508
Cash, cash equivalents, and restricted cash at end of year	47,183	135,765
Supplemental disclosures of cash flow information
Cash paid for interest	1,290	1,290
Supplemental disclosures of non-cash activities
Purchases of property and equipment included in accounts payable and accrued expenses	$ 1,815	811
Accretion of dividends on Series B, C, and D Preferred Stock		1,435
Conversion of convertible preferred stock into common stock upon completion of initial public offering		71,795
Reclassification of warrant liability to equity		$ 3,219